DESIGN, SYNTHESIS, AND CYTOTOXICITY EVALUATION OF NOVEL OPEN-CHAIN ANALOGUES OF ANTIMYCIN A 3 AS POTENTIAL ANTI-COLORECTAL CANCER AGENTS
Objective: Colorectal cancer is the third most common diagnosed cancer in the world. The aim of this work was to design, to synthesize, and to
evaluate the novel open-chain analogues of antimycin A
as highly potent anti-colorectal cancer agents.
Methods: Our analogue synthesis was designed by modifying the nine-membered dilactone moiety of antimycin A
with a simple open-chain
moiety, as well as introducing the stereocenter, and the hydroxyl groups on the side chain of the ester group. The synthesis was conducted through a
sequence of reactions from Boc-L-threonine by esterification, amidation, and sharpless asymmetric dihydroxylation. After completion the synthesis,
cytotoxicities of the analogues were evaluated as inhibitors of colorectal HCT-116 cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide cell proliferation assay.
Results: Novel open-chain analogues of antimycin A
were successfully synthesized in a good yield. The analogues exhibited a greater anticancer
activity against colorectal HCT-116 cells than the original antimycin A
with 50% inhibitory concentrations ranging of 35.0-47.0 ÂµM. The results
indicated that the presence of stereocenter and a hydroxylated open-chain moiety in the analogues were successfully improved its anti-colorectal
Conclusion: Our results clearly demonstrate that the opened-chain analogues of antimycin A
as a promising candidates of new anti-colorectal cancer
Keywords: Design, Synthesis, Open-chain, Analogue, Antimycin A
, Anti-colorectal cancer.
cancer statistics. CA Cancer J Clin 2011;61(2):69-90.
2. Gorlick R, Bertino JR. Drug resistance in colon cancer. Semin Oncol
3. Ueki M, Kusumoto A, Hanafi M, Shibata K, Tanaka T, Taniguchi M.
UK-3A, a novel antifungal antibiotic from Streptomyces sp. 517-02:
Fermentation, isolation, structural elucidation and biological properties.
J Antibiot (Tokyo) 1997;50(7):551-5.
4. Ueki M, Taniguchi M. The mode of action of UK-2A and UK-3A, novel
antifungal antibiotics from Streptomyces sp. 517-02. J Antibiot (Tokyo)
5. Arsianti A, Hanafi M, Saepudin E, Morimoto T, Kakiuchi K.
Synthesis and biological activity of 2-hydroxynicotinoyl-serinebutyl
6. Arsianti A, Tanimoto H, Morimoto T, Bahtiar A, Takeya T, Kakiuchi K.
Synthesis and anticancer activity of polyhydroxylated 18-membered
analogue of antimycin A
. Tetrahedron 2012;68(13):2884-91.
7. Arsianti A, Fadilah F, Kusmardi K, Tanimoto H, Morimoto, T,
Kakiuchi K. Design and molecular docking study of antimycin A
analogues as inhibitors of anti-apoptotic Bcl-2 of breast cancer. Open J
Med Chem 2014;4:79-86.
8. Miyoshi H, Tokutake N, Imaeda Y, Akagi T, Iwamura H. A model
of antimycin A binding based on structure-activity studies
of synthetic antimycin A analogues. Biochim Biophys Acta
9. Thomas G. Fundamentals of Medicinal Chemistry. 3
John Wiley & Sons Ltd.; 2003.
10. Xu D, Crispino GA, Sharpless KB. Selective asymmetric
dihydroxylation (AD) of dienes. J Am Chem Soc 1992;114(19):7570-1.
11. Gobel T, Sharpless KB. Temperature effects in asymmetric
dihydroxylation: Evidence for a stepwise mechanism. Angew Chem Int
Ed Engl 1993;32(9):1329-31.
12. Pettit GR, Smith TH, Feng S, Knight JC, Tan R, Pettit RK, et al.
Antineoplastic agents 561. Total synthesis of respirantin. J Nat Prod
13. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell
biology: New insights into their cellular reduction. Biotechnol Annu
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival:
Application to proliferation and cytotoxicity assays. J Immunol
15. Wu Y, Yang YQ. An expeditious enantioselective synthesis of antimycin
A3b. J Org Chem 2006; 71(11): 4296-301.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.